Skip to main content

Philip Fisher's 15 Points

Philip Fisher was one of the first investors to recognize that genuine growth stocks were fundamentally different investments than bargain-basement value plays. Rather than analyzing balance sheets and earnings reports in isolation, Fisher developed a systematic framework of qualitative factors that distinguished companies with sustainable competitive advantages from those merely riding temporary momentum.

Fisher's approach centered on something he called "scuttlebutt"—direct investigation through conversations with competitors, customers, suppliers, and industry participants to understand a company's true competitive position. Combined with rigorous analysis of management quality, R&D effectiveness, and capital allocation discipline, his 15 points created a comprehensive lens for identifying businesses capable of delivering extraordinary long-term returns.

Scuttlebutt as Primary Research​

What made Fisher revolutionary was his willingness to do primary research in real markets rather than relying exclusively on published financial statements. He would visit customer sites, speak with suppliers, attend industry conferences, and cultivate relationships with company executives and their rivals. Through these conversations, Fisher developed a texture for understanding competitive dynamics that no financial model could capture.

This methodology revealed truths that traditional financial analysis missed. A company might report steady revenue growth while losing its best customers, a dynamic that shows up in financial statements only with a lag. A competitor might be developing a product that would make a company's current offering obsolete, information available only through direct market intelligence. Fisher's scuttlebutt approach forced him to do the uncomfortable, often unglamorous work of understanding markets from first principles.

Management Quality and Capital Allocation​

Fisher placed extraordinary emphasis on management quality, recognizing that brilliant strategies executed by mediocre management rarely succeeded while solid strategies executed by exceptional management often exceeded expectations. He examined whether management had built wealth through the company's success (skin in the game) or were primarily collecting salaries. He evaluated the intellectual honesty of executives—did they acknowledge mistakes, or did they always spin poor results as external factors beyond their control?

Capital allocation discipline emerged as a critical discriminator. Fisher observed that the greatest creators of wealth were not always the fastest growers but those who deployed capital most efficiently. A company that grew at 15% while maintaining exceptional returns on incremental capital deployed often created more shareholder value than one growing 25% but burning through capital in the process.

Scientific R&D Management​

Fisher emphasized the importance of evaluating how companies managed research and development. Companies with scientific approaches to R&D—clear processes for evaluating project viability, disciplined go/no-go decision-making, and mechanisms for killing unproductive projects—typically generated innovation more reliably than those pursuing R&D as unfocused exploration. This distinction separated companies that consistently generated breakthrough products from those that occasionally stumbled on winners amid massive waste.

Practical Application Today​

Fisher's 15 points, developed in the 1950s for analyzing manufacturing businesses, remain remarkably relevant for modern growth investing. The specific factors have evolved—modern investors examine digital moats, unit economics, and network effects rather than purely production advantages—but the underlying methodology remains sound. Direct investigation, management quality assessment, and capital allocation analysis are just as critical today as they were decades ago.

This chapter explores Fisher's complete framework and shows how the same qualitative reasoning applies to identifying growth opportunities in contemporary markets, from software businesses to biotechnology to artificial intelligence companies.

Articles in this chapter​